Global Sterile Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug (Blood Factors, Cytokines, Immunoglobulins), Indication, Distribution - Forecast 2024-2030- Product Image

Sale

Global Sterile Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug (Blood Factors, Cytokines, Immunoglobulins), Indication, Distribution - Forecast 2024-2030

Report
197 Pages
March 2024
Region: Global
360iResearch™
ID: 5889402

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Sterile Injectable Drugs Market size was estimated at USD 518.49 billion in 2023, USD 568.62 billion in 2024, and is expected to grow at a CAGR of 10.17% to reach USD 1,021.81 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Sterile Injectable Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Sterile Injectable Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Sterile Injectable Drugs Market, highlighting leading vendors and their innovative profiles. These include Adare Pharma Solutions, Aenova Group, Almac Group, Avara Pharmaceutical Services, Inc., Baxter International Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., CordenPharma, Eli Lilly and Company, Evonik Industries AG, F. Hoffmann-La Roche Ltd, FAMAR Health Care Services, Fresenius Kabi Ag, Grifols S.A., Hikma Pharmaceuticals PLC, Jubilant Pharmova Limited, Lonza, Nexus Pharmaceuticals, Inc., Patheon, Inc. (Thermo Fischer), Pfizer Inc., Recipharm AB, and Siegfried Holding AG.

Market Segmentation & Coverage

This research report categorizes the Sterile Injectable Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Molecule Type
- Large Molecule
- Small Molecule
Drug
- Blood Factors
- Cytokines
- Immunoglobulins
- Insulin
- Monoclonal Antibodies (mAbs)
- Peptide Hormones
- Vaccine
Indication
- Autoimmune Diseases
- Cardiovascular & Metabolic Diseases
- Gastroenterology
- Hematology
- Infectious Diseases
- Neurology
- Oncology
Distribution
- E-commerce
- Hospital Pharmacy
- Retail Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Sterile Injectable Drugs Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Sterile Injectable Drugs Market?
What are the technology trends and regulatory frameworks in the Sterile Injectable Drugs Market?
What is the market share of the leading vendors in the Sterile Injectable Drugs Market?
Which modes and strategic moves are suitable for entering the Sterile Injectable Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Sterile Injectable Drugs Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases among population
5.1.1.2. Significant benefits and efficacy of sterile injectable drugs
5.1.1.3. Rise in healthcare spending and improved healthcare facilities
5.1.2. Restraints
5.1.2.1. High costs associated with sterile injectable drug manufacturing
5.1.3. Opportunities
5.1.3.1. Development of novel formulations and delivery methods
5.1.3.2. Growing expansion of sterile injectable drug manufacturing facilities
5.1.4. Challenges
5.1.4.1. Stringent approval and certification processes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Sterile Injectable Drugs Market, by Molecule Type

6.1. Introduction
6.2. Large Molecule
6.3. Small Molecule

7. Sterile Injectable Drugs Market, by Drug

7.1. Introduction
7.2. Blood Factors
7.3. Cytokines
7.4. Immunoglobulins
7.5. Insulin
7.6. Monoclonal Antibodies (mAbs)
7.7. Peptide Hormones
7.8. Vaccine

8. Sterile Injectable Drugs Market, by Indication

8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiovascular & Metabolic Diseases
8.4. Gastroenterology
8.5. Hematology
8.6. Infectious Diseases
8.7. Neurology
8.8. Oncology

9. Sterile Injectable Drugs Market, by Distribution

9.1. Introduction
9.2. E-commerce
9.3. Hospital Pharmacy
9.4. Retail Pharmacy

10. Americas Sterile Injectable Drugs Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Sterile Injectable Drugs Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Sterile Injectable Drugs Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Adare Pharma Solutions
14.1.2. Aenova Group
14.1.3. Almac Group
14.1.4. Avara Pharmaceutical Services, Inc.
14.1.5. Baxter International Inc.
14.1.6. Boehringer Ingelheim International GmbH
14.1.7. Catalent, Inc.
14.1.8. CordenPharma
14.1.9. Eli Lilly and Company
14.1.10. Evonik Industries AG
14.1.11. F. Hoffmann-La Roche Ltd
14.1.12. FAMAR Health Care Services
14.1.13. Fresenius Kabi Ag
14.1.14. Grifols S.A.
14.1.15. Hikma Pharmaceuticals PLC
14.1.16. Jubilant Pharmova Limited
14.1.17. Lonza
14.1.18. Nexus Pharmaceuticals, Inc.
14.1.19. Patheon, Inc. (Thermo Fischer)
14.1.20. Pfizer Inc.
14.1.21. Recipharm AB
14.1.22. Siegfried Holding AG
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. STERILE INJECTABLE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. STERILE INJECTABLE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. STERILE INJECTABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. STERILE INJECTABLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. STERILE INJECTABLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. STERILE INJECTABLE DRUGS MARKET DYNAMICS
FIGURE 7. STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 8. STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 10. STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. STERILE INJECTABLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. STERILE INJECTABLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. STERILE INJECTABLE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. STERILE INJECTABLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STERILE INJECTABLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 6. STERILE INJECTABLE DRUGS MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. STERILE INJECTABLE DRUGS MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 9. STERILE INJECTABLE DRUGS MARKET SIZE, BY BLOOD FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. STERILE INJECTABLE DRUGS MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. STERILE INJECTABLE DRUGS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. STERILE INJECTABLE DRUGS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. STERILE INJECTABLE DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODIES (MABS), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. STERILE INJECTABLE DRUGS MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. STERILE INJECTABLE DRUGS MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. STERILE INJECTABLE DRUGS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. STERILE INJECTABLE DRUGS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. STERILE INJECTABLE DRUGS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. STERILE INJECTABLE DRUGS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. STERILE INJECTABLE DRUGS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. STERILE INJECTABLE DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. STERILE INJECTABLE DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 25. STERILE INJECTABLE DRUGS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. STERILE INJECTABLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. STERILE INJECTABLE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 41. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 43. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 47. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES STERILE INJECTABLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. CHINA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 64. CHINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 65. CHINA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 67. INDIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 69. INDIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 75. JAPAN STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 77. JAPAN STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. JAPAN STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 99. THAILAND STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 101. THAILAND STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. THAILAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 114. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 118. EGYPT STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 120. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 122. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 126. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 130. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 136. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 138. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 148. NORWAY STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 150. NORWAY STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. NORWAY STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 152. POLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 153. POLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 154. POLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. POLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 156. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 157. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 158. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. QATAR STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 174. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 184. TURKEY STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 186. TURKEY STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. TURKEY STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM STERILE INJECTABLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 196. STERILE INJECTABLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 197. STERILE INJECTABLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 198. STERILE INJECTABLE DRUGS MARKET LICENSE & PRICING

Companies Mentioned

Adare Pharma Solutions
Aenova Group
Almac Group
Avara Pharmaceutical Services, Inc.
Baxter International Inc.
Boehringer Ingelheim International GmbH
Catalent, Inc.
CordenPharma
Eli Lilly and Company
Evonik Industries AG
F. Hoffmann-La Roche Ltd
FAMAR Health Care Services
Fresenius Kabi Ag
Grifols S.A.
Hikma Pharmaceuticals PLC
Jubilant Pharmova Limited
Lonza
Nexus Pharmaceuticals, Inc.
Patheon, Inc. (Thermo Fischer)
Pfizer Inc.
Recipharm AB
Siegfried Holding AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 568.62 Billion
Forecasted Market Value ( USD ) by 2030	$ 1021.81 Billion
Compound Annual Growth Rate	10.1%
Regions Covered	Global
No. of Companies Mentioned	22

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,789GBP €3621EUR$3,749USD£3,099GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4128EUR$4,274USD£3,533GBP €4587EUR$4,749USD£3,925GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4997EUR$5,174USD£4,276GBP €5552EUR$5,749USD£4,752GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5866EUR$6,074USD£5,020GBP €6518EUR$6,749USD£5,578GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7605EUR$7,874USD£6,508GBP €8450EUR$8,749USD£7,231GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Sterile Injectable Contract Manufacturing Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Sterile Injectable Drugs: Global Strategic Business Report

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034

Generic Oncology Sterile Injectable Global Market Report 2024

About the Sterile Injectable Drugs Market